Plus   Neg

Amadeus Posts Adj. Loss In FY; Revenue Down 61.0% - Quick Facts

Amadeus (AMADY.PK,AMADF.PK) reported a loss of 505.3 million euros for fiscal 2020 compared to profit of 1.11 billion euros, previous year. Adjusted loss was 302.4 million euros compared to profit of 1.26 billion euros. Adjusted loss per share was 0.68 euros compared to profit of 2.93 euros.

Fiscal 2020 revenue was 2.17 billion euros compared to 5.57 billion euros, last year.

Luis Maroto, President & CEO of Amadeus, said: "Despite a slight improvement in air traffic in the last quarter of the year, travel remained depressed in 2020 due to the COVID-19 pandemic. As such, the year finished with global air traffic declining by 65.9% compared to 2019. The situation still remains fluid. "

For comments and feedback contact: editorial@rttnews.com

Business News

Editors Pick
Johnson & Johnson's (JNJ) Covid-19 vaccine is expected to be back on track as early as this weekend as a decision is expected after the advisory panel meeting of the U.S. Centers for Disease Control and Prevention (CDC) slated on April 23, according to Dr. Anthony Fauci, the chief medical adviser to President Joe Biden. MK-4482, the experimental antiviral drug for COVID-19, showed promise to prevent and treat SARS-CoV-2 infection in hamster study, according to the scientists of National Institutes of Health or NIH. The drug significantly decreased levels of virus and disease damage in the lungs of hamsters treated for SARS-CoV-2 infection. MK-4482, delivered orally, is now in Phase 2 and 3 human clinical studies. Beverages giant Coca-Cola reported a 19 percent decline in profit for the second quarter from last year as a revenue growth of 5 percent and improved margins were offset by higher income taxes and interest expense. However, adjusted earnings per share and revenues topped analysts' expectations. The company also maintained its adjusted earnings and organic revenue growth outlook for fiscal 2021.
Follow RTT